Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

CDKN2A/CDK4 status in Brazilian patients meeting clinical criteria for hereditary melanoma: a cross-sectional descriptive trial.

International journal of dermatology - 1 Aug 2023

Arnaut Joyce R M B, Guimarães Isabella Dos S, Dos Santos Anna Cláudia E, Rodrigues Elizângela M, Machado Jorge R da S, de Melo Andreia C

Abstract excerpt

BACKGROUND: Melanoma is the most lethal skin cancer, and its incidence has increased worldwide. About 10% of cases are classified as hereditary melanoma (HM). CDKN2A and CDK4 are the major high-risk genes. Families are also more prone to develop pancreatic cancer, and different forms of oncological surveillance are recommended. OBJECTIVES: Describe the prevalence of CDKN2A/CDK4 germline mutations in...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Brazil
Share to Cross-Sectional Studies

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Cyclin-Dependent Kinase 4

Share to Cyclin-Dependent Kinase Inhibitor p16

Share to Germ-Line Mutation

Share to Melanoma

Share to Melanoma, Cutaneous Malignant

Share to Skin Neoplasms

Source

Identifiers

PMID: 37322831
DOI: 10.1111/ijd.16742

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

CDKN2A/CDK4 status in Brazilian patients meeting clinical criteria for hereditary melanoma: a cross-sectional descriptive trial.PMID 37322831Read ↗

Hereditary melanoma: a five-year study of Brazilian patients in a cancer referral center - phenotypic characteristics of probands and pathological features of primary tumors.Semantic proximity Read ↗

Germline CDKN2A mutations in Brazilian patients of hereditary cutaneous melanoma.Semantic proximity Read ↗

CDKN2A/CDK4 Status in Greek Patients with Familial Melanoma and Association with Clinico-epidemiological Parameters.Semantic proximity Read ↗

CDKN2A Polymorphism in Melanoma Patients in Colombian Population: A Case-Control Study.Semantic proximity Read ↗

Retrospective study of germline variants in patients with hereditary melanoma study criteria in a real clinical practice setting.Semantic proximity Read ↗

Molecular landscape of Hereditary Melanoma.Semantic proximity Read ↗

Germline Non-CDKN2A Variants in Melanoma and Associated Hereditary Cancer SyndromesSemantic proximity Read ↗

Characterization of individuals at high risk of developing melanoma in Latin America: bases for genetic counseling in melanoma.Semantic proximity Read ↗

[Recommendations for genetic testing and management of individuals genetically at-risk of cutaneous melanoma].Semantic proximity Read ↗

Familial Melanoma and Susceptibility Genes: A Review of the Most Common Clinical and Dermoscopic Phenotypic Aspect, Associated Malignancies and Practical Tips for ManagementSemantic proximity Read ↗

Genetic risk factors in melanoma etiopathogenesis and the role of genetic counseling: A concise review.Semantic proximity Read ↗

Genetic variations of patients with familial or multiple melanoma in Southern Brazil.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.